Wearable Biosensors Revolutionize Chronic Care: $18.9 Billion Market by 2030 as Demand for Continuous Monitoring Soars
Wearable biosensors are disrupting chronic disease management, offering patients and clinicians continuous, real-time health data that transforms treatment paradigms. These devices, from CGMs to smart watches with blood oxygen sensors, enable proactive interventions and reduce reliance on periodic lab tests. The wearable biosensor market, valued at $7.2 billion in 2023, is projected to reach...
0 Commentarios 0 Acciones 100 Views 0 Vista previa